RxDoctor Payments Data

Gregory Mindock, PA

Physician Assistant · Richland, MINPI 1790747665

Payments from drug & device makers

$1,959in general payments, 2019–2025

Across 51 payments — averaging $38.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$420
  • Boehringer Ingelheim$250
  • Amgen$195
  • AbbVie$180
  • AstraZeneca$170
  • Abbott$154
  • plus $589 from 12 others

What the payments were for

  • Food & beverage$1,959100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,959 in reported general payments places this provider in the 85th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$25,503
Medicare patients
144
Services billed
288

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide47$63,937
JardianceEmpagliflozin59$56,269
OzempicSemaglutide41$47,299
RybelsusSemaglutide22$34,979
EliquisApixaban35$27,288
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$22,419
TradjentaLinagliptin15$12,848
Atorvastatin Calcium448$6,461
Lantus SolostarInsulin Glargine,hum.Rec.Anlog32$3,812
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$2,936
Tamsulosin Hcl126$2,567
Metformin Hcl182$2,442
Metoprolol Succinate137$2,325
Levothyroxine Sodium203$2,285
Lisinopril251$2,015

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$420$82,27863 claims
Boehringer IngelheimJardiance, Tradjenta$250$69,11774 claims
Lilly USA, LLCTrulicity$33$63,93747 claims
PfizerEliquis$112$27,28835 claims
GSKTrelegy Ellipta$14$22,41923 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Richland

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →